Home

Subscription

February 2017 issue

January 2017 issue



BACK ISSUES

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006


2010 Issues

December 2010 Issue
• Appreciation and Anticipation
• New Therapeutic Agents Marketed in the United States in 2010
• Index for 2006 – 2010


November 2010 Issue
• Feature - Strike 3 – CVS Should be OUT!
• New Drug Review: Dabigatran etexilate mesylate (Pradaxa)


October 2010 Issue
• Feature - Prescription Benefit Programs – Pharmacy Needs Greater Strength and New Strategies!
• New Drug Review: Polidocanol (Asclera)


September 2010 Issue
• Feature - CARE is Missing in Health Insurance Reform! Independent Pharmacists are Well Positioned to Provide It!
• New Drug Review: Dienogest/estradiol valerate (Natazia)


August 2010 Issue
• Feature - Who are Pharmacy's Leaders?
• New Drug Review: Tocilizumab (Actemra)


July 2010 Issue
• Feature - We Have TOO MANY Colleges of Pharmacy!
• New Drug Review: Denosumab (Prolia)


June 2010 Issue
• Feature - CVS Caremark's Participation in Medicare Prescription Programs should be Terminated!
• New Drug Review: Pitavastatin calcium (Livalo)


May 2010 Issue
• Feature - Herb Denenberg – The Ultimate Activist and a Great Friend of Pharmacy
• New Drug Review: Dalfampridine (Ampyra)


April 2010 Issue
• Feature - Pharmacy Must Develop Opportunities Now! (Before Health Insurance "Reform" Limits our Role)
• New Drug Review: Liraglutide (Victoza)


March 2010 Issue
• Feature - Tobacco Sales in Pharmacies – A Historic Decision by APhA Delegates
• New Drug Review: Ustekinumab (Stelara)


February 2010 Issue
• Feature - Dispensing Error – And a Pharmacist in Prison
• New Drug Review: Iloperidone (Fanapt)


January 2010 Issue
• Feature - Health Care Reform – Let's Start Over and Do It Right!
• New Drug Review: Asenapine (Saphris)